To maximise on positive trends in the European polymerase chain reaction (PCR) reagents market, manufacturers need to widen their end-user base. This can be done by reinforcing the use of PCR by universities for academic research and developing newer platforms for the use of PCR reagents. Sustained long-term growth and wider end-user acceptance will be based on the ability of market participants to boost R&D investments and develop innovative technologies.
Recent analysis from Frost & Sullivan (drugdiscovery.frost.com), European PCR Reagents Market, finds that the market earned revenues of $349.9 million in 2006, and estimates this to reach $642.6 million in 2013.
If you are interested in a virtual brochure, which provides manufacturers, end users, and other industry participants with an overview of the latest analysis of the European PCR Reagents Market then send an email to Radhika Menon Theodore, Corporate Communications, at rmtheodore[.]frost.com with your full name, company name, title, telephone number, email address, city, state and country. We will send you an overview through email upon receipt of the above information.
Due to its multiple advantages, the concept of PCR is being widely explored. PCR is being deployed in research processes within several areas and, as a result, the PCR reagents market has been steadily expanding.
“The introduction of real-time PCR technique has opened newer avenues in molecular biology research and is supporting the growth of the real-time PCR reagents market across Europe,” notes Frost & Sullivan Research Analyst G.Haripriya. “Regular upgrades and the introduction of premixes has made the technology more sophisticated and user friendly, thereby encouraging end users to hike investments in the PCR reagents market.”
Many fields including forensic medicine, paternity testing and DNA sequencing are gradually starting to employ PCR technology. Accordingly, the end-user base for PCR reagents is increasing and the market is growing. At the same time, government funding for biotechnology research is motivating many end users to implement PCR in their laboratories.
However, the stability of reagents presents a major challenge to end users since PCR reagents are highly temperature sensitive and even mild moderations can affect their nature. From a competitive perspective, the entry of new participants also poses a challenge; many of these new companies have a niche clientele and threaten to capture market share from incumbents.
Furthermore, the trend of brand equity among end users is hindering the sale of other brands. Besides, the growing popularity of premixes is another factor that market participants have to grapple with.
“Due to its ease of use and manifold advantages, PCR is creating a buzz in the biotechnology industry and has emerged as one of the most preferred laboratory techniques for research,” adds Ms. Haripriya. “However, the major question gripping the industry is whether these technologies are cost-effective.”
Although there is a clear indication of their considerable benefits, the premium pricing of some of these technologies does not justify their use for routine processes. To leverage on future prospects, research efforts will need to be dedicated to making data yields more reliable and consistent.
“Against a backdrop of significant opportunities and intensifying competition, manufacturers need to address the issue of pricing and convince end users to invest in PCR reagents,” advises Ms. Haripriya. “As these processes require skilled labour to handle the reagents, laboratories need to ensure that their employees are well trained in such procedures and maintain the necessary laboratory conditions to secure beneficial results.”
European PCR Reagents Market is part of the Drug Discovery and Diagnostic Technologies Growth Partnership Service program, which also includes research services in the following: total European PCR reagents market, conventional PCR reagents and real-time PCR reagents. All research services included in subscriptions provide detailed market opportunities and industry trends that have been evaluated following extensive interviews with market participants. Interviews with the press are available.
About Frost & Sullivan
Frost & Sullivan, a global growth consulting company, has been partnering with clients to support the development of innovative strategies for more than 40 years. The company's industry expertise integrates growth consulting, growth partnership services, and corporate management training to identify and develop opportunities. Frost & Sullivan serves an extensive clientele that includes Global 1000 companies, emerging companies, and the investment community by providing comprehensive industry coverage that reflects a unique global perspective and combines ongoing analysis of markets, technologies, econometrics, and demographics.